Here are five facts:
1. Analysts have a 12-month price target of $25.67 on K2M shares.
2. On March 7, Director Carlos Ferrrer bought 38,942 K2M shares in a transaction worth nearly $500,015.
3. Last week, K2M shares opened at $14.07.
4. The company has a market cap of $580.08 million.
5. The 50-day moving average is $12.90 and 200-day moving average is $17.71.
More articles on devices:
Simplifying the joint replacement implant process — OpLogix’s computerized strategy
Spine implant to know: CentraLIF from Globus Medical
Device manufactures turning attention to outpatient setting: 3 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
